Org 10172

Known as: ORG10172, Org-10172, Organon 10172 
 
National Institutes of Health

Topic mentions per year

Topic mentions per year

1982-2017
05101519822017

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
Highly Cited
2001
Highly Cited
2001
BACKGROUND AND PURPOSE We sought to improve the reliability of the Trial of ORG 10172 in Acute Stroke Treatment (TOAST… (More)
  • table 1
  • table 2
  • table 3
  • table 4
Is this relevant?
Highly Cited
1999
Highly Cited
1999
OBJECTIVE To study the relation between acute blood glucose level and outcome from ischemic stroke. BACKGROUND Hyperglycemia… (More)
Is this relevant?
Highly Cited
1999
Highly Cited
1999
OBJECTIVE To examine the responses to early IV administration of an anticoagulant or placebo started within 24 hours of stroke… (More)
Is this relevant?
1995
1995
Rapid identification of stroke subtype is valuable for both practicing clinicians and the optimal design of clinical stroke… (More)
Is this relevant?
1993
1993
A pregnant woman treated with unfractionated heparin for pelvic vein thrombosis in the 26th week of her first pregnancy developed… (More)
Is this relevant?
1991
1991
A prospective, randomized, assessor-blind trial has been undertaken to compare the thromboprophylactic effect and safety of the… (More)
Is this relevant?
1990
1990
We evaluated the safety and possible efficacy of large doses of the heparinoid ORG 10172 in 57 patients with acute or progressing… (More)
  • table 1
  • figure 1
  • table 2
Is this relevant?
1989
1989
Studies were performed to determine the cross-reaction rate of the heparin-dependent antibody with Org 10172, a new low molecular… (More)
  • table 1
  • figure 1
  • figure 2
  • figure 3
Is this relevant?
1987
1987
In a double-blind, randomised trial Org 10172 low-molecular-weight (LMW) heparinoid was compared with placebo in the prevention… (More)
Is this relevant?
1987
1987
ORG 10172 is a heparinoid with mean molecular weight 6500 daltons. Intravenous bolus injections of ORG 10172 were compared with… (More)
Is this relevant?